Global Mesna (Mesnex) Market Size By Product Type (Oral, Injections), By Application (Hospital Pharmacies, Retail Pharmacies), By Geographic Scope And Forecast

Report ID: 23497|No. of Pages: 202

product image

Global Mesna (Mesnex) Market Size By Product Type (Oral, Injections), By Application (Hospital Pharmacies, Retail Pharmacies), By Geographic Scope And Forecast

Report ID: 23497|Published Date: Jan 2024|No. of Pages: 202|Base Year for Estimate: 2020|Format:   Report available in PDF formatReport available in Excel Format

Mesna (Mesnex) Market Size And Forecast

Mesna (Mesnex) Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2021 to 2028.

Increasing cancer incidence coupled with rising practices of chemotherapy has increased demand for Mesna. The chemotherapy is going through a phase of evolution and rapid progress leads to growth of the market during the forecast period. The Global Mesna (Mesnex) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=23497

Mesna (Mesnex) Market Size And Forecast

Global Mesna (Mesnex) Market Definition

Mesna, also known as Mesnex, is a medicine that is intended to reduce the risk of bladder hemorrhage in people who are taking cyclophosphamide or ifosfamide. It can be taken orally or injected into a vein. Headache, vomiting, tiredness, loss of appetite, cough, rash, and joint discomfort are all common adverse effects. Allergic responses are a serious negative effect. Although use during pregnancy appears to be safe for the infant, it has not been well researched. Mesna is a sulfur-containing organ sulfur chemical. It acts by making the cyclophosphamide and ifosfamide breakdown products present in the urine less harmful. In 1988, Mesna received FDA approval for medical use in the United States. It is listed as an essential medicine by the World Health Organization.

When a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy, Mesna is used to lower the risk of hemorrhagic cystitis and haematuria. In vivo, these two anticancer drugs can be transformed into urotoxic metabolites like acrolein. Mesna’s sulfhydryl group reacts with, unsaturated carbonyl-containing molecules like acrolein to help detoxify these metabolites. A Michael addition is the name for this reaction. Mesna also improves cysteine excretion in the urine. It can be given intravenously or orally (through the mouth). Oral Mesna would be administered with oral cyclophosphamide, and IV Mesna would be given with IV ifosfamide.

Due to bioavailability difficulties, oral Mesna doses must be doubled compared to IV Mesna doses. Instead of staying four to five days in the hospital for all of the IV Mesna infusions, patients can leave sooner with the oral preparation. Mesna lowers the toxicity of urotoxic chemicals that may arise as a result of chemotherapy. Mesna is a water-soluble antioxidant chemical that is given in combination with the chemotherapy drugs cyclophosphamide and ifosfamide. Mesna concentrates in the bladder, where acrolein accumulates after chemotherapy and forms a conjugate with acrolein and other urotoxic metabolites via a Michael addition. The urotoxic chemicals are converted to innocuous metabolites by this conjugation event. After then, the metabolites are eliminated in the urine.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=23497

Global Mesna (Mesnex) Market Overview

Mesna is taken as a pill or injected into the veins at two and six hours after each ifosfamide dose as a prophylactic medication to lower the risk of ifosfamide-induced hemorrhagic cystitis when used in conjunction with normal antineoplastic therapy. The daily dose of Mesna is hundreds of times higher than that of ifosfamide. Mesnex (Mesna) tablets are a type of tablet. The need for Mesna has increased as the incidence of cancer has increased, as has the use of chemotherapy. Chemotherapy is in the process of evolving and progressing rapidly. Cancer cases were anticipated to reach 1,735,350 in 2018, and this number is expected to rise by 3% each year.

Clinical research for new treatments like hemorrhagic cystitis is boosting the market’s growth and increasing FDA approvals for new therapeutics, which is allowing Mesna to expand its reach. Ifosfamide and cyclophosphamide, two chemotherapy medications, can irritate the bladder lining. This can induce bladder bleeding, which can show up as blood in your urine (pee). This is referred to as haematuria. Mesna protects your bladder against irritation and bleeding by acting as a barrier.

Ifosfamide is always given with Mesna. The majority of persons who receive cyclophosphamide treatment do not receive dosages high enough to cause bladder hemorrhage. They will not require the use of Mesna. However, if your treatment includes high doses of cyclophosphamide, you will be given Mesna. If you’re taking a high dose of cyclophosphamide, your doctor can tell you. Outside of North America, Mesna is also utilized as a mucolytic agent, similar to acetylcysteine it’s marked as Mistabron and Mistabronco for this purpose.

Global Mesna (Mesnex) Market: Segmentation Analysis

The Global Mesna (Mesnex) Market is Segmented on the basis of Product Type, Application, and Geography.

Mesna (Mesnex) Market Segmentation Analysis

Mesna (Mesnex) Market, By Product Type

  • Oral
  • Injections

Mesna (Mesnex) Market, By Product Type

Based on Product Type, The market is segmented into Oral and Injections. The Oral Segment was dominated Global Mesna (Mesnex) Market during the forecast period. Due to bioavailability difficulties, oral Mesna doses must be doubled compared to IV Mesna doses. Instead of staying four to five days in the hospital for all of the IV Mesna infusions, patients can leave sooner with the oral preparation.

Mesna (Mesnex) Market, By Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Mesna (Mesnex) Market By Product By Application

Based on Application, The market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. During the forecast period, Retail Pharmacies held the largest share of the market. Future pharmacies will be high-tech shopping malls with services like telemedicine and point-of-care diagnostics. The major players have already begun to incorporate more technology into their operations.

Mesna (Mesnex) Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

On the basis of Geography, The Global Mesna (Mesnex) Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. In the future years, North America is expected to reach the largest share during the forecast period. Chemotherapy is undergoing numerous R&D phases as a result of expansion, which includes an increase in cancer occurrences combined with the expanding use of chemotherapy. Clinical trials are still being conducted for new treatments, and the FDA is approving more new drugs.

Key Players

The “Global Mesna (Mesnex) Market” study report will provide a valuable insight with an emphasis on the global market including some of the major player’s such as Sagent Pharmaceuticals, Athenex Pharmaceuticals, Fresenius Kabi, Baxter, Mylan, Teva Pharmaceutical, Gland Pharma Limited, Hikma Pharmaceuticals, and Jiangsu Hengrui Medicine.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Mesna (Mesnex) Market Key Developments And Mergers

• In July 2019, Mylan and Upjohn, a division of Pfizer, will merge, forming a new global health champion that is uniquely positioned to meet the world’s medical needs.

• In January 2022, Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical business, has entered into a license agreement with Medication Patent Pool (MPP) in the Middle East and North Africa (MENA) region for molnupiravir, MSD’s investigational oral COVID-19 antiviral medicine.

Report Scope

REPORT ATTRIBUTESDETAILS
STUDY PERIOD

2017-2028

BASE YEAR

2020

FORECAST PERIOD

2021-2028

HISTORICAL PERIOD

2017-2019

KEY COMPANIES PROFILED

Sagent Pharmaceuticals, Athenex Pharmaceuticals, Fresenius Kabi, Baxter, Mylan, Teva Pharmaceutical, Gland Pharma Limited.

SEGMENTS COVERED
  • By Product Type
  • By Application
  • By Geography
CUSTOMIZATION SCOPE

Free report customization (equivalent to up to 4 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.

Top Trending Reports:

Global Sodium Petroleum Sulfonate Market Size And Forecast

Global Butterfly Valves Market Size And Forecast

Research Methodology of Verified Market Research:

Research Methodology of VMR

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

Frequently Asked Questions

Increasing cancer incidence coupled with rising practices of chemotherapy has increased demand for Mesna. The chemotherapy is going through a phase of evolution and rapid progress leads to growth of the market during the forecast period.

The major players are Sagent Pharmaceuticals, Athenex Pharmaceuticals, Fresenius Kabi, Baxter, Mylan, Teva Pharmaceutical, Gland Pharma Limited.

The Global Mesna (Mesnex) Market is Segmented on the basis of Product Type, Application, and Geography.

The sample report for the Mesna (Mesnex) Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.
1. INTRODUCTION OF GLOBAL MESNA (MESNEX) MARKET 1.1. Overview of the Market 1.2. Scope of Report 1.3. Assumptions 2. EXECUTIVE SUMMARY 3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH 3.1. Data Mining 3.2. Validation 3.3. Primary Interviews 3.4. List of Data Sources 4. GLOBAL MESNA (MESNEX) MARKET OUTLOOK 4.1. Overview 4.2. Market Dynamics 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.3. Porters Five Force Model 4.4. Value Chain Analysis 5. GLOBAL MESNA (MESNEX) MARKET, BY TYPE 5.1. Overview 5.2. Oral 5.3. Injections 6. GLOBAL MESNA (MESNEX) MARKET, BY APPLICATION 6.1. Overview 6.2. Hospital Pharmacies 6.3. Retail Pharmacies 6.4. Online Pharmacies 7. GLOBAL MESNA (MESNEX) MARKET, BY GEOGRAPHY 7.1. Overview 7.2. North America 7.2.1. U.S. 7.2.2. Canada 7.2.3. Mexico 7.3. Europe 7.3.1. Germany 7.3.2. U.K. 7.3.3. France 7.3.4. Rest of Europe 7.4. Asia Pacific 7.4.1. China 7.4.2. Japan 7.4.3. India 7.4.4. Rest of Asia Pacific 7.5. Rest of the World 7.5.1. Latin America 7.5.2. Middle East & Africa 8. GLOBAL MESNA (MESNEX) MARKET COMPETITIVE LANDSCAPE 8.1. Overview 8.2. Company Market Ranking 8.3. Key Development Strategies 9. COMPANY PROFILES 9.1. Sagent Pharmaceuticals 9.1.1. Overview 9.1.2. Financial Performance 9.1.3. Product Outlook 9.1.4. Key Developments 9.2. Athenex Pharmaceuticals 9.2.1. Overview 9.2.2. Financial Performance 9.2.3. Product Outlook 9.2.4. Key Developments 9.3. Fresenius Kabi 9.3.1. Overview 9.3.2. Financial Performance 9.3.3. Product Outlook 9.3.4. Key Developments 9.4. Baxter 9.4.1. Overview 9.4.2. Financial Performance 9.4.3. Product Outlook 9.4.4. Key Developments 9.5. Mylan 9.5.1. Overview 9.5.2. Financial Performance 9.5.3. Product Outlook 9.5.4. Key Developments 9.6. Teva Pharmaceutical 9.6.1. Overview 9.6.2. Financial Performance 9.6.3. Product Outlook 9.6.4. Key Developments 9.7. Gland Pharma Limited 9.7.1. Overview 9.7.2. Financial Performance 9.7.3. Product Outlook 9.7.4. Key Developments 9.8. Hikma Pharmaceuticals 9.8.1. Overview 9.8.2. Financial Performance 9.8.3. Product Outlook 9.8.4. Key Developments 9.9. Jiangsu Hengrui Medicine 9.9.1. Overview 9.9.2. Financial Performance 9.9.3. Product Outlook 9.9.4. Key Developments 10. Appendix 10.1. Related Reports

Report Research Methodology

Research methodology

Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.

This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.

We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:

Exploratory data mining

Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.

All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.

expert data mining

For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.

Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.

Data Collection Matrix

PerspectivePrimary ResearchSecondary Research
Supplier side
  • Fabricators
  • Technology purveyors and wholesalers
  • Competitor company’s business reports and newsletters
  • Government publications and websites
  • Independent investigations
  • Economic and demographic specifics
Demand side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customer

Econometrics and data visualization model

data visualiztion model

Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.

All the research models are customized to the prerequisites shared by the global clients.

The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.

Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.

Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.

Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:

  • Market drivers and restraints, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2027

We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.

Primary validation

The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.

The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.

primary validation

Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:

  • Established market players
  • Raw data suppliers
  • Network participants such as distributors
  • End consumers

The aims of doing primary research are:

  • Verifying the collected data in terms of accuracy and reliability.
  • To understand the ongoing market trends and to foresee the future market growth patterns.

Industry Analysis Matrix

Qualitative analysisQuantitative analysis
  • Global industry landscape and trends
  • Market momentum and key issues
  • Technology landscape
  • Market’s emerging opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2027
  • Market revenue estimates and forecasts up to 2027, by technology
  • Market revenue estimates and forecasts up to 2027, by application
  • Market revenue estimates and forecasts up to 2027, by type
  • Market revenue estimates and forecasts up to 2027, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Mesna (Mesnex) Market

report-detail

Download Sample Report

View More Reports